These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 103092)

  • 1. [Pathomorphology of tuberculous and post-tuberculous changes depending on the L-transformation of Mycobacteria in the patient's body].
    Nurusheva AM
    Probl Tuberk; 1978 Nov; (11):75-8. PubMed ID: 103092
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathomorphological characteristics of tuberculosis in relation to the variability of the causative agent].
    Puzik VI; Zemskova ZS; Dorozhkova IR; Nurusheva AM
    Probl Tuberk; 1981 Jul; (7):50-4. PubMed ID: 6792629
    [No Abstract]   [Full Text] [Related]  

  • 3. [The significance of L-form mycobacteria in the development of pulmonary tuberculosis].
    Snitinskaia OS; Sibirnaia RI; Beliakova OI
    Vrach Delo; 1990 Mar; (3):38-40. PubMed ID: 2114701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estimation of the degree of risk of reactivation of residual tuberculous changes based on the status of mycobacterial population].
    Krudu VN; Dorozhkova IR
    Probl Tuberk; 1992; (5-6):45-7. PubMed ID: 1409517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation of mycobacteria L forms as a prognostic criterion of recurrence and aggravation of tuberculosis in patients with extended residual tuberculous lesions of the lungs].
    Dorozhkova IR; Karachunskiĭ MA; Abdullaeva ET; Gamzaeva NF; Kochetkova EIa
    Probl Tuberk; 1989; (3):14-8. PubMed ID: 2498865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [L forms of Mycobacterium tuberculosis and their clinico-epidemiological significance].
    Anastasatu C; Moldovan O
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(3):203-13. PubMed ID: 3001898
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of L variants of Mycobacteria in the development and clinical course of recurrences of pulmonary tuberculosis].
    Berezovskiĭ BA; Salobaĭ RIu
    Probl Tuberk; 1988; (4):32-5. PubMed ID: 3138685
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical value of detection of L forms of Mycobacterium tuberculosis in patients with residual tuberculous changes in the lungs].
    Dorozhkova IR; Krudu VN; Popesku TT
    Probl Tuberk; 1990; (12):5-8. PubMed ID: 2128124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of qualitative changes in the Mycobacteria population during the treatment of middle-aged and elderly patients with newly detected pulmonary tuberculosis].
    Dorozhkova IR; Karachunskiĭ MA; Kochetkova EIa
    Probl Tuberk; 1990; (4):7-11. PubMed ID: 2118647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of mycobacterial L forms in the development of pulmonary tuberculosis relapses].
    Salobaĭ RIu; Berezovskiĭ BA; Golanov VS
    Vrach Delo; 1981 Dec; (12):77-80. PubMed ID: 6800136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of biological properties of the causative agent in patients with pulmonary tuberculosis exposed to prolonged low-dose radiation].
    Gurevich GL; Abramovskaia AK; Dorozhkova IR; Surkova LK
    Probl Tuberk; 1993; (2):46-8. PubMed ID: 7984571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endogenous reactivation of tuberculosis as a result of reversion of persistent mycobacterial L-forms].
    Dorozhkova IR; Zemskova ZS; Krudu VN; Kochetkova EIa
    Probl Tuberk; 1995; (3):43-6. PubMed ID: 7617636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Forms of persistance of tuberculosis mycobacteria in healthy subjects with regard to human tuberculosis].
    Dorozhkova IR; Zemskova ZS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):115-9. PubMed ID: 4205254
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of the L transformation and reversion of the causative agent in the epidemiology of tuberculosis].
    Khomenko AG; Kochemasova ZN; Dykhno MM; Zemskova ZS; Dorozhkova IR
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):9-14. PubMed ID: 6428092
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-anatomical and microbiological research on the residual changes following spontaneously cured tuberculosis].
    Solov'eva IP; Dorozhkova IR; Biron MG
    Probl Tuberk; 1986; (8):58-61. PubMed ID: 3095824
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of morphological changes in the lungs of guinea pigs after administration of ultra-small forms of Mycobacteria obtained from patients with tuberculosis].
    Khomenko AG; El'shanskaia MP; Akhunov ShB; Golyshevskaia VI
    Probl Tuberk; 1986; (6):46-50. PubMed ID: 3092208
    [No Abstract]   [Full Text] [Related]  

  • 17. [The antilysozyme activity of Mycobacterium tuberculosis L forms].
    Bukharin OV; Usviatsov BIa; Golanov VS
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):27-8. PubMed ID: 10925868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological risks of tuberculous infection foci in patients discharging L forms of Mycobacterium tuberculosis].
    Khomenko AG; Muratov VV
    Probl Tuberk; 1993; (2):2-5. PubMed ID: 7984560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of ultrasmall forms of Mycobacteria in the pathomorphology of tuberculosis].
    Golyshevskaia VI
    Probl Tuberk; 2003; (3):26-30. PubMed ID: 12744059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on pathogenicity of sputum from cavity of sputum negative patients with pulmonary tuberculosis after short course chemotherapy].
    Feng H; Du B; Dong Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Sep; 23(9):559-62. PubMed ID: 11778533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.